RBM On Other Exchanges
Symbol
Exchange
Mumbai

rubra medicaments ltd (RBM) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RUBRA MEDICAMENTS LTD (RBM)
\

Related News

No related news articles were found.

rubra medicaments ltd (RBM) Related Businessweek News

No Related Businessweek News Found

rubra medicaments ltd (RBM) Details

Rubra Medicaments Limited engages in the trading of pharmaceuticals, and other medical and surgical products. The company was incorporated in 1991 and is based in Mumbai, India. Rubra Medicaments Limited is a subsidiary of Rubra Pharmaceuticals Limited.

Founded in 1991

rubra medicaments ltd (RBM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rubra medicaments ltd
Rubra Medicaments Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019

Rubra Medicaments Limited announced standalone audited earnings results for the fourth quarter and full year ended March 31, 2019. For the quarter, the company reported revenues from operations of INR 3.0 million against INR 3.408 million a year ago. Profit for the period was INR 1.318 million against loss of INR 1.534 million a year ago. For the year, the company reported revenues from operations of INR 5.912 million against INR 22.980 million a year ago. Loss for the period was INR 0.114 million against INR 1.637 million a year ago.

Rubra Medicaments Limited to Report Q4, 2019 Results on May 24, 2019

Rubra Medicaments Limited announced that they will report Q4, 2019 results on May 24, 2019

Rubra Medicaments Limited, Board Meeting, May 24, 2019

Rubra Medicaments Limited, Board Meeting, May 24, 2019. Agenda: To discuss and approve standalone audited financial result for the quarter and year ended March 31, 2019.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

RBM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RBM.
View Industry Companies
 

Industry Analysis

RBM

Industry Average

Valuation RBM Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RUBRA MEDICAMENTS LTD, please visit www.rubramed.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.